Liquid Genomics

Liquid Genomics Overview

Founded 2013
Status Acquired/​Merged
Employees 5
Latest Deal Type M&A
Latest Deal Amount $7.24M
Latest Deal Amount

Liquid Genomics General Information


Provider of blood-based biomarker intended to be used for tumor profiling. The company's blood-based biomarker utilizes non-invasive blood-based molecular testing methods enabling cancer patients to assess gene mutations, expressions, and fusions to inform treatment strategies for chemotherapy.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 9920 Jefferson Boulevard
  • Culver City, CA 90501
  • United States
+1 (310) 000-0000

Liquid Genomics Timeline

Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Liquid Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Mar-2017 $7.24M 00.000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Jan-2017 00.000 00.000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Mar-2016 $3.24M $3.24M 00.000 Completed Generating Revenue

Liquid Genomics Cap Table

To view Liquid Genomics‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000

Liquid Genomics Executive Team (2)

Name Title Board Seat Contact Info
Kathleen Danenberg Co-Founder, Board Member, President & Chief Executive Officer

1 Former Executive

Ready to get started?

Request a free trial